NCT03760094

Brief Summary

Lymphadenopathy is defined as an abnormality in the size or character of lymph nodes caused by the invasion or propagation of either inflammatory or neoplastic cells into the nodes Accurate lymph node characterization is important for a wide number of clinical situations, including prognosis, prediction, selecting and monitoring treatment, beyond the diagnosis itself (cancer, lymphoma, or inflammatory nodes)

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 30, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

December 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

November 30, 2018

Status Verified

November 1, 2018

Enrollment Period

1 year

First QC Date

November 29, 2018

Last Update Submit

November 29, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • The percentage of patients with benign lymphadenopathy

    comparison with the biopsy result

    one year

Study Arms (1)

Study group

EXPERIMENTAL

patients with lymphadenopathy

Device: Colour Doppler

Interventions

evaluation of lymph nodes by Doppler

Study group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • clinically enlarged lymph nodes

You may not qualify if:

  • previous medical treatment or radiotherapy
  • previous biopsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 29, 2018

First Posted

November 30, 2018

Study Start

December 1, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2020

Last Updated

November 30, 2018

Record last verified: 2018-11